Stay updated with breaking news from Kode Biotech. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
/PRNewswire/ -- The "Glycomics/Glycobiology Market Share, Size, Trends, Industry Analysis Report, By Product , By Application, By End-Use, By Region, Segment...
/PRNewswire/ -- The "Global Glycomics/Glycobiology Market by Product (Enzymes (Glycosidases, Transferases), Instruments (Mass Spectrometry, Chromatography,...
Scoop Community provides New Zealand Community news and views
A >5-fold increase. The addition of motixafortide to G-CSF also allowed 88.3% of patients to undergo transplantation after only one apheresis session, compared to 10.8% in the G-CSF arm - an... | March 16, 2022
/cloudfront-ap-southeast-2.images.arcpublishing.com/nzme/RDUYMK2AQHJQV3DWOWBNJ2OH4E.jpg)
Covid 19 coronavirus: Kiwi tech could offer low-cost immunity test 22 Feb, 2021 01:41 AM 4 minutes to read Kiwi-developed technology - using "synthetic paint" to coat the outside of our red blood cells - could offer a low-cost way to test for Covid-19 immunity. Photo / USCDC Kiwi-developed technology - using "synthetic paint" to coat the outside of our red blood cells - could offer a low-cost way to test for Covid-19 immunity. Photo / USCDC Kiwi-developed technology - using "synthetic paint" to coat the outside of our red blood cells - could offer a low-cost way to test for Covid-19 immunity....